OBJECTIVES: To determine trends in the prevalence and aetiological distribution of genital ulcer syndrome (GUS) in a cohort of female bar workers and to assess factors associated with these trends. METHODS: An open cohort of 600 women at high risk of HIV and sexually transmitted infection (STI) was offered screening and treatment for STI at 3-month intervals. The prevalence of GUS and associated aetiological agents (Herpes simplex virus (HSV), Treponema pallidum and Haemophilus ducreyi) were monitored over 27 months through clinical examination, dry lesion swabbing and multiplex polymerase chain reaction. The effects of HIV status and other factors on the prevalence trends of STI were assessed. RESULTS: A total of 753 women were recruited into the cohort over 10 examination rounds. At recruitment, the seroprevalence was 67% for HIV and 89% for HSV type 2 (HSV-2). During follow-up, 57% of ulcers had unknown aetiology, 37% were due to genital herpes and 6% to bacterial aetiologies, which disappeared completely in later rounds. The absolute prevalence of genital herpes remained stable at around 2%. The proportion of GUS caused by HSV increased from 22% to 58%, whereas bacterial causes declined. These trends were observed in both HIV-negative and HIV-positive women. CONCLUSIONS: The changes observed in the frequency and proportional distribution of GUS aetiologies suggest that regular STI screening and treatment over an extended period can effectively reduce bacterial STI and should therefore be sustained. However, in populations with a high prevalence of HSV-2, there remains a considerable burden of genital herpes, which soon becomes the predominant cause of GUS. Given the observed associations between genital herpes and HIV transmission, high priority should be given to the evaluation of potential interventions to control HSV-2 either through a vaccine or through episodic or suppressive antiviral therapy and primary prevention.
OBJECTIVES: To determine trends in the prevalence and aetiological distribution of genital ulcer syndrome (GUS) in a cohort of female bar workers and to assess factors associated with these trends. METHODS: An open cohort of 600 women at high risk of HIV and sexually transmitted infection (STI) was offered screening and treatment for STI at 3-month intervals. The prevalence of GUS and associated aetiological agents (Herpes simplex virus (HSV), Treponema pallidum and Haemophilus ducreyi) were monitored over 27 months through clinical examination, dry lesion swabbing and multiplex polymerase chain reaction. The effects of HIV status and other factors on the prevalence trends of STI were assessed. RESULTS: A total of 753 women were recruited into the cohort over 10 examination rounds. At recruitment, the seroprevalence was 67% for HIV and 89% for HSV type 2 (HSV-2). During follow-up, 57% of ulcers had unknown aetiology, 37% were due to genital herpes and 6% to bacterial aetiologies, which disappeared completely in later rounds. The absolute prevalence of genital herpes remained stable at around 2%. The proportion of GUS caused by HSV increased from 22% to 58%, whereas bacterial causes declined. These trends were observed in both HIV-negative and HIV-positive women. CONCLUSIONS: The changes observed in the frequency and proportional distribution of GUS aetiologies suggest that regular STI screening and treatment over an extended period can effectively reduce bacterial STI and should therefore be sustained. However, in populations with a high prevalence of HSV-2, there remains a considerable burden of genital herpes, which soon becomes the predominant cause of GUS. Given the observed associations between genital herpes and HIV transmission, high priority should be given to the evaluation of potential interventions to control HSV-2 either through a vaccine or through episodic or suppressive antiviral therapy and primary prevention.
Authors: C Y Chen; R C Ballard; C M Beck-Sague; Y Dangor; F Radebe; S Schmid; J B Weiss; V Tshabalala; G Fehler; Y Htun; S A Morse Journal: Sex Transm Dis Date: 2000-01 Impact factor: 2.830
Authors: Eline L Korenromp; Roel Bakker; Sake J De Vlas; N Jamie Robinson; Richard Hayes; J Dik F Habbema Journal: Sex Transm Dis Date: 2002-04 Impact factor: 2.830
Authors: J Anderson; R A Clark; D H Watts; M Till; C Arrastia; P Schuman; S E Cohn; M Young; L Bessen; R Greenblatt; M Vogler; S Swindells; P Boyer Journal: J Acquir Immune Defic Syndr Hum Retrovirol Date: 1996-12-01
Authors: Prashini Moodley; Patrick D J Sturm; Trusha Vanmali; David Wilkinson; Cathy Connolly; A Willem Sturm Journal: Sex Transm Dis Date: 2003-03 Impact factor: 2.830
Authors: Brigitte Jordan-Harder; Leonard Maboko; Donan Mmbando; Gabriele Riedner; Elisabeth Nägele; Juan Harder; Volker Küchen; Albert Kilian; Rolf Korte; Frank V Sonnenburg Journal: AIDS Date: 2004-01-23 Impact factor: 4.177
Authors: G Riedner; M Rusizoka; O Hoffmann; F Nichombe; E Lyamuya; D Mmbando; L Maboko; P Hay; J Todd; R Hayes; M Hoelscher; H Grosskurth Journal: Sex Transm Infect Date: 2003-10 Impact factor: 3.519
Authors: Rupert Kaul; Joshua Kimani; Nico J Nagelkerke; Karoline Fonck; Elizabeth N Ngugi; Florence Keli; Kelly S MacDonald; Ian W Maclean; Job J Bwayo; Marleen Temmerman; Allan R Ronald; Stephen Moses Journal: JAMA Date: 2004-06-02 Impact factor: 56.272
Authors: Jim Todd; Gabriele Riedner; Leonard Maboko; Michael Hoelscher; Helen A Weiss; Eligius Lyamuya; David Mabey; Mary Rusizoka; Laurent Belec; Richard Hayes Journal: PLoS One Date: 2013-03-13 Impact factor: 3.240